Inclusion body myositis and chronic lymphocytic leukemia: A case series

Neurology

Volumn 83, Issue 1, 2014, Pages 98-99

  Beck, Elizabeth H ^a   Amato, Anthony A ^a   Greenberg, Steven A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; CD57 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; DNA BINDING PROTEIN; GLYCOPROTEIN P 15095; LEUKOSIALIN; METHOTREXATE; PREDNISONE;

ADULT; AGED; B LYMPHOCYTE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; CD3+ T LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; DYSPHAGIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INCLUSION BODY MYOSITIS; INFLAMMATORY CELL; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; MALE; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE STRENGTH; MUSCLE WEAKNESS; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE;

AGED; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MYOSITIS, INCLUSION BODY;

EID: 84903980463     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000546     Document Type: Note

References (6)

1. Arnardottir S, Ansved T, Nennesmo I, Borg K. Report of a patient with inclusion body myositis and CD81 chronic lymphocytic leukaemia: post-mortem analysis of muscle and brain. Acta Neurol Scand 2001;103: 131-135.
2. Larman HB, Salajegheh M, Nazareno R, et al. Cytosolic 59-nucleotidase 1A autoimmunity in sporadic inclusion body myositis. Ann Neurol 2013;73: 408-418.
3. Badrising UA, Maat-Schieman M, van Duinen SG, et al. Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology 2000;55: 1385-1387.
4. Hodgson K, Ferrer G, Montserrat E, Moreno C. Chronic lymphocytic leukemia and autoimmunity: a systematic review. Haematologica 2011;96: 752-761.
5. Friedman J, Schattner A, Shvidel L, Berrebi A. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but under-recognized association. Semin Arthritis Rheum 2006;35: 306-311.
6. National Institute of Occupational Safety and Health. Lifetime Risk (Percent) of Being Diagnosed With Cancer by Site and Race/Ethnicity. Available at: http://www.cdc.gov/niosh/docket/archive/pdfs/NIOSH-209/0209-040110-nci.pdf. Accessed December 16, 2013.